CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 248 enrolled
Drug / intervention
ketorolacdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00524264
NCT00524264Phase 3Completed
CompareCT.gov

A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery

Allergan·interventional·Posted Sep 3, 2007·Updated Oct 1, 2009

In Brief

A Phase 3 clinical trial evaluating ketorolac for Cataract Extraction and 2 related conditions. Completed, enrolled 248 participants across 1 site.

Detailed Summary

This is a 16-day study to evaluate the safety and efficacy of ketorolac eye drops for the treatment of inflammation and pain associated with cataract surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract Extraction, Pain, Inflammation
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 3, 2007
Enrollment StartOct 1, 2007
Primary CompletionApr 1, 2008
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 18.8 years ago

Interventions

ketorolacdrug

Ophthalmic drops, BID pre- and post-operation, and 6 doses on surgery day. Placebo